Nitric oxide synthase and reduced arterial tone contribute to arteriovenous malformation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37235659.
- Also identified by DOI 10.1126/sciadv.ade7280 and PMC identifier 10219588.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mechanisms underlying arteriovenous malformations (AVMs) are poorly understood. Using mice with endothelial cell (EC) expression of constitutively active Notch4 (Notch4*<sup>EC</sup>), we show decreased arteriolar tone in vivo during brain AVM initiation. Reduced vascular tone is a primary effect of Notch4*<sup>EC</sup>, as isolated pial arteries from asymptomatic mice exhibited reduced pressure-induced arterial tone ex vivo. The nitric oxide (NO) synthase (NOS) inhibitor NG-nitro-l-arginine (L-NNA) corrected vascular tone defects in both assays. L-NNA treatment or endothelial NOS (<i>eNOS</i>) gene deletion, either globally or specifically in ECs, attenuated AVM initiation, assessed by decreased AVM diameter and delayed time to moribund. Administering nitroxide antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl also attenuated AVM initiation. Increased NOS-dependent production of hydrogen peroxide, but not NO, superoxide, or peroxynitrite was detected in isolated Notch4*<sup>EC</sup> brain vessels during AVM initiation. Our data suggest that eNOS is involved in Notch4*<sup>EC</sup>-mediated AVM formation by up-regulating hydrogen peroxide and reducing vascular tone, thereby permitting AVM initiation and progression.
Medical subject headings
- Arteriovenous Malformations
- Hydrogen Peroxide
- Nitric Oxide Synthase Type III